Author:
Qiang Li,Huili Zhang,Leilei Zhang,Xiaoyan Wang,Hui Wang,Biao Huang,Yigang Wang,Fang Huang,Yiqiang Wang
Funder
the Public Welfare Technology Project of Zhejiang Province
Zhejiang Medical Technology Plan Project
Hangzhou Science and Technology Bureau
Hangzhou Medical Health Science and Technology Project
the National Natural Science Foundation of China
the Applied Research and Cultivation Program of Jiangxi Province
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference44 articles.
1. Bailly C, Thuru X, Goossens L, Goossens JF (2023) Soluble TIM-3 as a biomarker of progression and therapeutic response in cancers and other of human diseases. Biochem Pharmacol 209:115445
2. Cao W, Li M, Liu J, Zhang S, Noordam L, Verstegen MMA, Wang L, Ma B, Li S, Wang W, Bolkestein M, Doukas M, Chen K, Ma Z, Bruno M, Sprengers D, Kwekkeboom J, van der Laan LJW, Smits R, Peppelenbosch MP, Pan Q (2020) LGR5 marks targetable tumor-initiating cells in mouse liver cancer. Nat Commun 11:1961
3. Chen K, Ma J, Jia X, Ai W, Ma Z, Pan Q (2019) Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans. Biochim Biophys Acta 1871:117–125
4. Chen L, Hong J, Hu R, Yu X, Chen X, Zheng S, Qin Y, Zhou X, Wang Y, Zheng L, Fang H, Liu P, Huang B (2021) clinical value of combined detection of serum sTim-3 and pepsinogen for gastric cancer diagnosis. Cancer Manag Res 13:7759–7769
5. Chen L, Qin Y, Lin B, Yu X, Zheng S, Zhou X, Liu X, Wang Y, Huang B, Jin J, Wang L (2022a) Clinical value of the sTim-3 level in chronic kidney disease. Exp Ther Med 24:606
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献